Nimonata, Marvin .
HRN: 27-87-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/10/2025
10/16/2025
IV
4.5g IV
Q6
CAP HR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes